The Safety Securing and the Safety Monitoring of Herbal Medicines, Finished Herbal Products and Supplements |
| K. Toriizuka and K. Tsutani |
| J. Pharm. Soc. Jpn., 128(6),835-836, 2008 |
|
The Safety of Health Foods and Importance of Their Origin |
| Y. Goda |
| J. Pharm. Soc. Jpn., 128(6),837-838, 2008 |
|
Legal Situations of Supplements in the United States and European Union |
| H. Ohama |
| J. Pharm. Soc. Jpn., 128(6),839-850, 2008 |
|
Preparedness Response to Hazard and Toxic Incidents, and Food Terrorism |
| T. Yoshida |
| J. Pharm. Soc. Jpn., 128(6),851-857, 2008 |
|
How to Use Medical and Drug Information? The View of Integrated Information Handling |
| H. Toyotama |
| J. Pharm. Soc. Jpn., 128(6),859-866, 2008 |
|
Regulatory Sciences in Herbal Medicines and Dietary Supplements |
| K. Tsutani and H. Takuma |
| J. Pharm. Soc. Jpn., 128(6),867-880, 2008 |
|
Development of Assay Methods for Endogenous Inorganic Sulfur Compounds and Sulfurtransferases and Evaluation of the Physiological Functions of Bound Sulfur |
| S. Tanabe |
| J. Pharm. Soc. Jpn., 128(6),881-900, 2008 |
|
Expressions and Regulations of Renal Sodium-Cotransporters and -Antiporters, and Related-Transport Proteins |
| Y. Suketa |
| J. Pharm. Soc. Jpn., 128(6),901-917, 2008 |
|
Development of Highly Selective and Sensitive Fluorescent and Chemiluminescent Reagents |
| M. Nakazono |
| J. Pharm. Soc. Jpn., 128(6),919-924, 2008 |
|
Application of Text Mining Approach to Pre-education prior to Clinical Practice |
| M. Koinuma, K. Koike, and H. Nakamura |
| J. Pharm. Soc. Jpn., 128(6),925-931, 2008 |
|
Antimutagenic Activity of a Novel Ascorbic Derivative, Disodium Isostearyl 2-O-L-Ascorbyl Phosphate |
| M. Hisama, S. Matsuda, H. Shibayama, and M. Iwaki |
| J. Pharm. Soc. Jpn., 128(6),933-940, 2008 |
|
Pharmacokinetics and Biodistribution of Paclitaxel-loaded Pluronic P105/L101 Mixed Polymeric Micelles |
| Y. Wang, Y. Li, Q. Wang, J. Wu, and X. Fang |
| J. Pharm. Soc. Jpn., 128(6),941-950, 2008 |
|
Drug Delivery to the Colon Using a Novel One-Step Dry-Coated Tablets (OSDrC) |
| M. Sakurai, Y. Ozeki, M. Ando, H. Okamoto, and K. Danjo |
| J. Pharm. Soc. Jpn., 128(6),951-957, 2008 |
|
Measurement of Amount of Fentanyl Remaining in Used Patches: Investigation of Clinical Factors Affecting the Remaining Amounts in 4 Patients |
| K. Yamamoto, M. Kojima, H. Iguchi, and T. Ohta |
| J. Pharm. Soc. Jpn., 128(6),959-964, 2008 |
|
Evidence Based Quality Management of the Clinical Formulations: Determination of the Expiration Date of the Powdered Medicine Prepared by Grinding Tablets |
| K. Tsutsumi, C. Tsuchiya, K. Hanawa, M. Suzuki, T. Hanawa, and T. Oguchi |
| J. Pharm. Soc. Jpn., 128(6),965-970, 2008 |
|
Analytical Data of Designated Substances (Shitei-Yakubutsu) Controlled by the Pharmaceutical Affairs Law in Japan, Part I: GC-MS and LC-MS |
| R. Kikura-Hanajiri, M. Kawamura, N. Uchiyama, J. Ogata, H. Kamakura, K. Saisho, and Y. Goda |
| J. Pharm. Soc. Jpn., 128(6),971-979, 2008 |
|
Analytical Data of Designated Substances (Shitei-Yakubutsu) Controlled by the Pharmaceutical Affairs Law in Japan, Part II: Color Test and TLC |
| N. Uchiyama, M. Kawamura, H. Kamakura, R. Kikura-Hanajiri, and Y. Goda |
| J. Pharm. Soc. Jpn., 128(6),981-987, 2008 |